November 6, 2003
Willkie client Pharmion Corporation announced its $84 million initial public offering of 6 million shares of common stock at $14.00 per share.
On November 6, Willkie client Pharmion Corporation announced its $84 million initial public offering of 6 million shares of common stock at $14.00 per share. All of the shares are being offered by Pharmion, which is creating a global pharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients. The November 7 issue of The Daily Deal notes that the issuer was represented by Willkie partners Peter Jakes and William Gump, and associates Heath Golden and Thomas Mark.
